Emittent / Herausgeber: BÖAG Börsen AG / Schlagwort(e): Personalie Wechsel in Vorstand und Aufsichtsrat der BÖAG Börsen AG 30.04.2024 / 17:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PRESSEMITTEILUNG Wechsel in Vorstand und Aufsichtsrat der BÖAG Börsen AG Dr. Thomas Ledermann folgt Jürgen Kösters und übernimmt Aufsichtsratsvorsitz Sven Marxsen als Geschäftsführer der Börsen Düsseldorf, Hamburg und Hannover vorgeschlagen Aufsichtsrat in neuer Zusammensetzung Düsseldorf/Hamburg/Hannover, 30. April 2024 – Nach heutigem Beschlus...
Total voting rights Foresight VCT PLCLEI: 213800GNTY699WHACF46 Total Voting Rights30 April 2024 In conformity with DTR 5.6.1R, the Company announces that, as at 30 April 2024, the Company's issued share capital consisted of 269,420,666 Ordinary Shares. There are no shares held in Treasury. The total number of voting rights of the Company is 269,420,666. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the FCA's Disclosu...
Rexel Annual Shareholders’ Meeting REXEL ANNUAL SHAREHOLDERS’ MEETING OF APRIL 30, 2024 Rexel’s Combined Shareholders' Meeting was held today in Paris under the Chairmanship of Agnès Touraine, Chairwoman of the Board of Directors. All resolutions were approved by the shareholders. The results of the votes and the audio webcast are available on the Company's website: (section: Investor/Event/ Annual General Shareholders’ Meeting 2024). Payout of 1.20 euros per share The Shareholders’ Meeting approved the distribution of an amount of 1.20 euros per share (in line with the payout policy ...
ASSEMBLEE GENERALE DE REXEL ___________________________________________________________________________________________ ASSEMBLEE GENERALE DE REXEL DU 30 AVRIL 2024 _______________________________________________________________________________________ L’Assemblée générale mixte des actionnaires de Rexel s’est tenue ce jour à Paris sous la présidence d’Agnès Touraine, Présidente du Conseil d’Administration. Les actionnaires ont approuvé toutes les résolutions. Le résultat des votes et le webcast audio sont disponibles sur le site de la Société : www. rexel.com (rubrique : Investisseu...
Total voting rights FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42 Total Voting Rights30 April 2024 In conformity with DTR 5.6.1R, the Company announces that, as at 30 April 2024, the Company's issued share capital consisted of 273,876,056 Ordinary Shares. There are no shares held in Treasury. The total number of voting rights of the Company is 273,876,056. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the FCA...
EZCORP to Release Second Quarter Fiscal 2024 Results After Market Close on Wednesday, May 1, 2024 AUSTIN, Texas, April 30, 2024 (GLOBE NEWSWIRE) -- EZCORP, Inc. (NASDAQ: EZPW) will issue second quarter fiscal 2024 financial results (period ended March 31, 2024) on Wednesday, May 1 after the market close. The Company will host a webcast and conference call at 9:00 a.m. Eastern Time on Thursday, May 2 to discuss its results. The presentation slides will be posted to the Investor Relations section of our website after the market close on Wednesday, May 1. The details for the webcast are: ...
A director at BSL Corporation Berhad bought 88,000,000 shares at 0.030MYR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
EQS-News: FCR Immobilien AG / Schlagwort(e): Jahresergebnis FCR Immobilien AG bestätigt vorläufige Zahlen und schließt Geschäftsjahr 2023 erfolgreich ab 30.04.2024 / 17:15 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. FCR Immobilien AG bestätigt vorläufige Zahlen und schließt Geschäftsjahr 2023 erfolgreich ab Gesamtumsatz um 58 % auf 56,6 Mio. Euro gestiegen Robustes Ergebnis: EBT bei 10,1 Mio. Euro, FFO bei 8,2 Mio. Euro Dividende von 0,25 Euro je Aktie als Vorschlag der Verwaltung Kennzahlen zum Immobilienportfolio weiter ver...
EQS-News: Allane SE / Schlagwort(e): Jahresbericht/Prognose Allane Mobility Group veröffentlicht Geschäftsbericht 2023 30.04.2024 / 17:05 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. PRESSEMITTEILUNGAllane Mobility Group veröffentlicht Geschäftsbericht 2023 Konzernvertragsbestand steigt um 8,5% auf 125.800 Verträge Operativer Konzernumsatz* wächst um 13,9 % auf 342,7 Mio. Euro Ergebnis vor Steuern mit 12,6 Mio. Euro im Rahmen der Prognose Dividendenvorschlag von 0,09 Euro je Aktie Pullach, 30. April 2024 – Die Allane Mobility G...
EQS-News: Shelly Group AD / Key word(s): AGM/EGM Shelly Group convenes Annual General Meeting 30.04.2024 / 17:00 CET/CEST The issuer is solely responsible for the content of this announcement. Shelly Group convenes Annual General Meeting Sofia / Munich, 30 April 2024 – Shelly Group AD (Ticker SLYG / ISIN: ) (“Shelly Group” / “the Company“), a provider of IoT and smart building solutions based in Sofia, Bulgaria, convenes its Annual General Meeting to be held on 4 June 2024 at 10.00 CEST / 11.00 EEST in Sofia, Bulgaria. Further information can be found at: .About Shelly G...
EQS-News: SCHOTT Pharma AG & Co. KGaA / Schlagwort(e): Personalie SCHOTT Pharma ernennt Tobias Erfurth zum Leiter Investor Relations 30.04.2024 / 17:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SCHOTT Pharma ernennt Tobias Erfurth zum Leiter Investor Relations Tobias Erfurth übernimmt Leitung des Investor Relations-Teams ab Mitte August 2024 Er verfügt über mehr als 20 Jahre Erfahrung im Finanz- und Kapitalmarktsektor sowie im Bereich Investor Relations SCHOTT Pharma, ein Pionier für pharmazeutische Aufbewahrungs- und Verabrei...
EQS-News: Allane SE / Key word(s): Annual Report/Forecast Allane Mobility Group publishes Annual Report 2023 30.04.2024 / 17:05 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASEAllane Mobility Group publishes Annual Report 2023 Group contract portfolio increases by 8.5% to 125,800 contracts Consolidated operating revenue* grows by 13.9% year-on-year to EUR 342.7 million Earnings before taxes of EUR 12.6 million in line with full year guidance Dividend proposal of EUR 0.09 per share Pullach, 30 April 2024 – Allane Mobility Gr...
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Personnel SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations 30.04.2024 / 17:00 CET/CEST The issuer is solely responsible for the content of this announcement. SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations Tobias Erfurth will lead Investor Relations Team starting in August 2024. He brings more than 20 years of experience in finance, capital markets and investor relations. SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, today announced the appoi...
EQS-News: Shelly Group AD / Schlagwort(e): Hauptversammlung Shelly Group beruft ordentliche Hauptversammlung ein 30.04.2024 / 17:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Shelly Group beruft ordentliche Hauptversammlung ein Sofia / München, 30. April 2024 – Die Shelly Group AD (Ticker SLYG / ISIN: („Shelly Group” / „die Gesellschaft“), ein Anbieter von IoT- und Smart-Building-Lösungen mit Sitz in Sofia, Bulgarien, beruft ihre ordentliche Hauptversammlung ein, die am 4. Juni 2024 um 10.00 Uhr MESZ / 11.00 Uhr OESZ in Sofia, B...
Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management Not for distribution to United States news wire services or for dissemination in the United States TORONTO and HOUSTON, April 30, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA) (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, announced today the closing of its previously announced CA$20 million investment by RA Capital Management, a multi-stage investment manager based in Boston, MA, by ...
A director at Tracsis maiden bought 4,814 shares at 872p and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
A director at Qatar Insurance Co bought 200,000 shares at 0.000QAR and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.